Shringar House of Mangalsutra Q2 FY27 Revenue Up 55% to ₹819 Cr, PAT Jumps 73% to ₹39.5 Cr
Shringar House of Mangalsutra reported a 55% YoY revenue growth to ₹819 crore for Q2 FY27. PAT surged 73% to ₹39.5 crore. H1 FY27 revenue grew 58.7% to ₹1,367 crore, with PAT up 43.1% to ₹73.5 crore. EBITDA margin improved to 6.7% in Q2 FY27. Operational cash outflow reduced significantly.
The substantial double-digit percentage growth in key financial metrics like revenue and profit signifies a significant positive impact on the company's financial health and market position.
The company has reported strong year-on-year growth in revenue, profit after tax, and EBITDA, along with an improvement in operational cash flow, indicating positive financial performance.
Shringar House of Mangalsutra Limited has announced its Un-Audited Standalone Financial Results for the Quarter and Half-yearly ended 30th September, 2026. The company reported a significant year-on-year growth, with revenue from operations for Q2 FY27 increasing by 54.8% to ₹818.7 crore, compared to ₹528.8 crore in Q2 FY26. For the half-yearly period, revenue from operations grew by 58.7% to ₹1,367.15 crore in H1 FY27 from ₹861.41 crore in H1 FY26.
Profit After Tax (PAT) also saw a substantial increase, rising by 73.2% to ₹39.5 crore in Q2 FY27 from ₹22.8 crore in Q2 FY26. For H1 FY27, PAT grew by 43.1% YoY to ₹73.47 crore from ₹51.3 crore in H1 FY26.
EBITDA for Q2 FY27 increased by 68.7% to ₹54.9 crore, with an EBITDA margin of 6.7%, up from 6.2% in Q2 FY26. For H1 FY27, EBITDA rose by 40.8% to ₹103.9 crore, with an EBITDA margin of 7.60%.
The company's operational cash outflow improved significantly, reducing to -₹77.91 crore in H1 FY27 from -₹412.11 crore in H1 FY26. The Debt/Equity ratio stood at 0.3x as at H1 FY27.
In terms of production, the company sold 5,557 kgs in Q2 FY27, a 10% increase from 5,255 kgs in Q2 FY26. The company also highlighted its expanded capacity, with approximately ₹15 crore invested in a new manufacturing facility, which resumed commercial production from February 23, 2026, and is expected to ramp up in the coming quarters.
What to do with a filing like this
Shringar House of Mangalsutra Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shringar House of Mangalsutra Limited. Read the original for the full detail.